Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy (Q37655012)
Jump to navigation
Jump to search
scientific article published on 10 January 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy |
scientific article published on 10 January 2014 |
Statements
1 reference
Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy (English)
1 reference
Susan O'Brien
1 reference
John C Byrd
1 reference
Jeffrey Jones
1 reference
Danelle F James
1 reference
Jennifer A Woyach
1 reference
Laura Rassenti
1 reference
Gerard Lozanski
1 reference
Arletta Lozanski
1 reference
Weiqiang Zhao
1 reference
Fong Clow
1 reference
Kami Maddocks
1 reference
Amy S Ruppert
1 reference
Rose Mantel
1 reference
Kelly Smucker
1 reference
Emanuela Ghia
1 reference
Lisa L Smith
1 reference
Yiming Zhong
1 reference
David Lucas
1 reference
Katie Williams
1 reference
Thomas J Kipps
1 reference
Joseph Flynn
1 reference
Richard R Furman
1 reference
Amy J Johnson
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference